Search NLS News

The company has announced a new collaboration with the research group of Dr. Thuy Tran at the Department of Oncology-Pathology, Karolinska Institutet.

The agreement enables access to Ankyras clinical decision-support software with the Siemens Healthineers ARTIS icono angiography systems and includes joint promotional activities through the ARTIS icono product platform.

As a policy insider who has dealt with the intricacies of life science, I am aware of the challenge of taking a molecule from bench to bedside. It’s an arduous journey that more often than not ends in disappointment. Policy work follows a surprisingly similar trajectory. Years of work for passing a minor legislative change may, in the end, yield little to nothing. 

A jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed in a patent dispute between Maquet Cardiovascular and Abiomed.

The Uppsala site has been established to support scientific collaboration, application development and resin innovation.

Last month, The Life Science Cluster attracted a record number of investors to its annual Investor Partnering Day in Oslo. Interest in life sciences is clearly growing. But why and why now?

Skape Bio and researchers at the University of Washington’s Institute for Protein Design (IPD) have announced a peer-reviewed study published in Nature demonstrating a new way to design protein-based medicines for G protein-coupled receptors, or GPCRs.

The new center in Freiburg is dedicated to the development and production of quality-critical materials for the cell and gene therapy market.

The two companies have partnered to offer an integrated development and manufacturing pathway for recombinant protein programs in E. coli.

The agreement for distribution and commercialization of Pepaxti in Central and Eastern Europe addresses a market potential of approximately SEK 150 million and enables potential sales uptake in this region earlier than previously planned, the company states.